25 XP   0   0   10

Hoth Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Hoth Therapeutics Inc together

PenkeI guess you are interested in Hoth Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hoth Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hoth Therapeutics Inc

I send you an email if I find something interesting about Hoth Therapeutics Inc.

Quick analysis of Hoth Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Hoth Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
4.2%

What is your share worth?

Current worth
$2.03
Expected worth in 1 year
$2.88
How sure are you?
41.7%

+ What do you gain per year?

Total Gains per Share
$0.85
Return On Investment
72.6%

For what price can you sell your share?

Current Price per Share
$1.17
Expected price per share
$1.15 - $1.67
How sure are you?
50%

1. Valuation of Hoth Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$1.17

Intrinsic Value Per Share

$-42.57 - $-50.28

Total Value Per Share

$-40.54 - $-48.25

2. Growth of Hoth Therapeutics Inc (5 min.)




Is Hoth Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$8.8m$8.2m$2m20.2%

How much money is Hoth Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m-$2.9m$1m52.7%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Hoth Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#689 / 1010

Most Revenue
#959 / 1010

Most Profit
#293 / 1010

Most Efficient
#400 / 1010

What can you expect buying and holding a share of Hoth Therapeutics Inc? (5 min.)

Welcome investor! Hoth Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Hoth Therapeutics Inc.

What can you expect buying and holding a share of Hoth Therapeutics Inc?

First you should know what it really means to hold a share of Hoth Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Hoth Therapeutics Inc is $1.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hoth Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hoth Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.03. Based on the TTM, the Book Value Change Per Share is $0.21 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hoth Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.39-33.5%-0.43-37.0%-0.56-48.0%-0.54-45.7%-0.47-39.8%
Usd Book Value Change Per Share-0.39-33.3%0.2118.1%-0.27-23.4%0.108.6%0.087.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.39-33.3%0.2118.1%-0.27-23.4%0.108.6%0.087.2%
Usd Price Per Share1.44-2.01-2.31-2.71-2.26-
Price to Earnings Ratio-0.92--1.16--1.28--1.75--1.46-
Price-to-Total Gains Ratio-3.69-0.68--2.81-19.87-19.87-
Price to Book Ratio0.71-0.85-1.83-9.33-7.78-
Price-to-Total Gains Ratio-3.69-0.68--2.81-19.87-19.87-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.17
Number of shares854
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.210.10
Usd Total Gains Per Share0.210.10
Gains per Quarter (854 shares)181.2786.04
Gains per Year (854 shares)725.06344.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
107257151343334
20145014401687678
3021752165210301022
4029002890313741366
5036253615417171710
6043504340420612054
7050755065524042398
8058015790627482742
9065266515630913086
10072517240734353430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.024.00.00.0%0.024.00.00.0%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%9.011.00.045.0%10.013.01.041.7%10.013.01.041.7%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.023.04.2%1.00.023.04.2%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%9.011.00.045.0%10.013.01.041.7%10.013.01.041.7%

Fundamentals of Hoth Therapeutics Inc

About Hoth Therapeutics Inc

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation, which is in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-004 for treatment of asthma and allergies using inhalational administration; HT-003 for the treatment of acne and psoriasis, as well as inflammatory bowel diseases; and HT-002, a novel peptide for treating COVID-19. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform which is in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus, as well as a diagnostic device through a mobile device. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; Virginia Commonwealth University; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. It also has a research collaboration agreement with Weill Cornell Medicine to develop HT-003. Hoth Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York.

Fundamental data was last updated by Penke on 2024-04-11 10:55:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hoth Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hoth Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Hoth Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hoth Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Hoth Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hoth Therapeutics Inc to the Biotechnology industry mean.
  • -17.9% Return on Assets means that Hoth Therapeutics Inc generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hoth Therapeutics Inc:

  • The MRQ is -17.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.9%TTM-16.8%-1.1%
TTM-16.8%YOY-33.9%+17.1%
TTM-16.8%5Y-35.7%+18.9%
5Y-35.7%10Y-40.7%+5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.9%-13.3%-4.6%
TTM-16.8%-12.8%-4.0%
YOY-33.9%-11.7%-22.2%
5Y-35.7%-13.9%-21.8%
10Y-40.7%-15.7%-25.0%
1.1.3. Return on Equity

Shows how efficient Hoth Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hoth Therapeutics Inc to the Biotechnology industry mean.
  • -19.3% Return on Equity means Hoth Therapeutics Inc generated $-0.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hoth Therapeutics Inc:

  • The MRQ is -19.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -19.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.3%TTM-19.1%-0.2%
TTM-19.1%YOY-40.9%+21.8%
TTM-19.1%5Y-50.7%+31.6%
5Y-50.7%10Y-62.8%+12.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.3%-16.9%-2.4%
TTM-19.1%-16.1%-3.0%
YOY-40.9%-15.1%-25.8%
5Y-50.7%-19.3%-31.4%
10Y-62.8%-20.2%-42.6%

1.2. Operating Efficiency of Hoth Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hoth Therapeutics Inc is operating .

  • Measures how much profit Hoth Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hoth Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hoth Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y--632.4%+632.4%
1.2.2. Operating Ratio

Measures how efficient Hoth Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Hoth Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y-7.876-7.876

1.3. Liquidity of Hoth Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hoth Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 13.89 means the company has $13.89 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Hoth Therapeutics Inc:

  • The MRQ is 13.892. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.607. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ13.892TTM9.607+4.285
TTM9.607YOY10.088-0.481
TTM9.6075Y19.675-10.068
5Y19.67510Y18.649+1.025
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.8923.890+10.002
TTM9.6074.173+5.434
YOY10.0885.344+4.744
5Y19.6756.126+13.549
10Y18.6496.448+12.201
1.3.2. Quick Ratio

Measures if Hoth Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hoth Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 13.69 means the company can pay off $13.69 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hoth Therapeutics Inc:

  • The MRQ is 13.692. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.486. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ13.692TTM9.486+4.206
TTM9.486YOY10.704-1.218
TTM9.4865Y22.272-12.786
5Y22.27210Y19.790+2.482
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.6923.514+10.178
TTM9.4863.998+5.488
YOY10.7045.380+5.324
5Y22.2726.105+16.167
10Y19.7906.404+13.386

1.4. Solvency of Hoth Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hoth Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hoth Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.07 means that Hoth Therapeutics Inc assets are financed with 7.4% credit (debt) and the remaining percentage (100% - 7.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hoth Therapeutics Inc:

  • The MRQ is 0.074. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.122. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.074TTM0.122-0.048
TTM0.122YOY0.144-0.022
TTM0.1225Y0.135-0.013
5Y0.13510Y0.150-0.015
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0740.339-0.265
TTM0.1220.336-0.214
YOY0.1440.271-0.127
5Y0.1350.366-0.231
10Y0.1500.389-0.239
1.4.2. Debt to Equity Ratio

Measures if Hoth Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hoth Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.0% means that company has $0.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hoth Therapeutics Inc:

  • The MRQ is 0.080. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.141. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.080TTM0.141-0.061
TTM0.141YOY0.174-0.033
TTM0.1415Y0.229-0.088
5Y0.22910Y0.294-0.066
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0800.388-0.308
TTM0.1410.402-0.261
YOY0.1740.335-0.161
5Y0.2290.426-0.197
10Y0.2940.461-0.167

2. Market Valuation of Hoth Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Hoth Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Hoth Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -0.92 means the investor is paying $-0.92 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hoth Therapeutics Inc:

  • The EOD is -0.747. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.920. Based on the earnings, the company is expensive. -2
  • The TTM is -1.162. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.747MRQ-0.920+0.172
MRQ-0.920TTM-1.162+0.242
TTM-1.162YOY-1.283+0.121
TTM-1.1625Y-1.752+0.590
5Y-1.75210Y-1.460-0.292
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.747-2.264+1.517
MRQ-0.920-2.629+1.709
TTM-1.162-2.680+1.518
YOY-1.283-4.145+2.862
5Y-1.752-6.257+4.505
10Y-1.460-6.254+4.794
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hoth Therapeutics Inc:

  • The EOD is -0.414. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.510. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.186. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.414MRQ-0.510+0.096
MRQ-0.510TTM-1.186+0.677
TTM-1.186YOY-1.005-0.181
TTM-1.1865Y-2.226+1.040
5Y-2.22610Y-1.855-0.371
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.414-2.973+2.559
MRQ-0.510-3.333+2.823
TTM-1.186-3.553+2.367
YOY-1.005-5.605+4.600
5Y-2.226-8.376+6.150
10Y-1.855-8.865+7.010
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hoth Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.71 means the investor is paying $0.71 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Hoth Therapeutics Inc:

  • The EOD is 0.577. Based on the equity, the company is cheap. +2
  • The MRQ is 0.710. Based on the equity, the company is cheap. +2
  • The TTM is 0.851. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.577MRQ0.710-0.133
MRQ0.710TTM0.851-0.141
TTM0.851YOY1.835-0.984
TTM0.8515Y9.331-8.480
5Y9.33110Y7.776+1.555
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5771.896-1.319
MRQ0.7102.115-1.405
TTM0.8512.093-1.242
YOY1.8352.884-1.049
5Y9.3313.542+5.789
10Y7.7763.916+3.860
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Hoth Therapeutics Inc.

3.1. Institutions holding Hoth Therapeutics Inc

Institutions are holding 7.069% of the shares of Hoth Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc0.892803880400
2023-12-31Geode Capital Management, LLC0.540702350100
2023-12-31UBS Group AG0.1943084474297103.5422
2023-12-31JPMorgan Chase & Co0.14580633763370
2023-12-31Tower Research Capital LLC0.03580155815580
2023-12-31Royal Bank of Canada0.0055024000
2023-12-31Wells Fargo & Co0.0007030625
2023-12-31McGlone Suttner Wealth Management Inc0.0005020200
2023-12-31Morgan Stanley - Brokerage Accounts0.00010600
2023-12-31Advisor Group Holdings, Inc.0.00010400
2023-12-31BlackRock Inc001-1-50
2023-09-30Integrated Wealth Concepts LLC000-10000-100
2023-09-30Citadel Advisors Llc000-20428-100
2023-12-31Virtu Financial LLC000-12746-100
2023-12-31TWO SIGMA SECURITIES, LLC000-16773-100
Total 1.8163078948-47730-60.5%

3.2. Funds holding Hoth Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.88110.00013880400
2024-02-29Fidelity Extended Market Index0.39010.000117180-83-0.4808
2024-02-29Spartan Total Market Index Pool E0.07970350900
2024-02-29Fidelity Series Total Market Index0.06280276400
2024-02-29Fidelity Nasdaq Composite Index0.04510198800
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.03670161700
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.02950129920.1542
2023-12-31SSgA U.S. Extended Market Index Class I0.02460.0001108400
2024-03-31State St US Extended Mkt Indx NL Cl C0.02460.0001108400
2023-12-31Northern Trust Extended Eq Market Idx0.0157069000
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0157069000
2023-12-31SSgA U.S. Total Market Index Strategy0.00710313-7-2.1875
2024-02-29Spartan Extended Market Index Pool E0.0028012283212.8205
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.001205200
2023-12-31NT US Market Cap Idx Fd - L0.000703000
2023-12-31Northern Trust Wilshire 50000.000703000
Total 1.61810.000471256-50.0%

3.3. Insider Transactions

Insiders are holding 0.934% of the shares of Hoth Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-09-19Robb KnieBUY100000.39
2022-09-19Robb KnieBUY100000.39
2022-09-16Robb KnieBUY100000.4

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Hoth Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3900.212-284%-0.274-30%0.101-488%0.084-562%
Book Value Per Share--2.0272.366-14%1.889+7%1.915+6%1.630+24%
Current Ratio--13.8929.607+45%10.088+38%19.675-29%18.649-26%
Debt To Asset Ratio--0.0740.122-39%0.144-48%0.135-45%0.150-51%
Debt To Equity Ratio--0.0800.141-43%0.174-54%0.229-65%0.294-73%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Eps---0.391-0.433+11%-0.562+43%-0.535+37%-0.466+19%
Free Cash Flow Per Share---0.706-0.486-31%-0.539-24%-0.473-33%-0.412-42%
Free Cash Flow To Equity Per Share---0.7060.165-528%0.152-564%209.711-100%174.784-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---50.280--------
Intrinsic Value_10Y_min---42.571--------
Intrinsic Value_1Y_max---2.706--------
Intrinsic Value_1Y_min---2.657--------
Intrinsic Value_3Y_max---9.909--------
Intrinsic Value_3Y_min---9.424--------
Intrinsic Value_5Y_max---19.254--------
Intrinsic Value_5Y_min---17.718--------
Market Cap5085334.800-23%6261305.7608715220.240-28%10060921.990-38%11786797.600-47%9822331.333-36%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.577-23%0.7100.851-17%1.835-61%9.331-92%7.776-91%
Pe Ratio-0.747+19%-0.920-1.162+26%-1.283+39%-1.752+91%-1.460+59%
Price Per Share1.170-23%1.4402.005-28%2.315-38%2.712-47%2.260-36%
Price To Free Cash Flow Ratio-0.414+19%-0.510-1.186+133%-1.005+97%-2.226+337%-1.855+264%
Price To Total Gains Ratio-2.999+19%-3.6920.676-646%-2.814-24%19.869-119%19.869-119%
Quick Ratio--13.6929.486+44%10.704+28%22.272-39%19.790-31%
Return On Assets---0.179-0.168-6%-0.339+90%-0.357+99%-0.407+128%
Return On Equity---0.193-0.191-1%-0.409+112%-0.507+162%-0.628+225%
Total Gains Per Share---0.3900.212-284%-0.274-30%0.101-487%0.085-561%
Usd Book Value--8815295.00010284814.500-14%8209823.250+7%8323069.650+6%7086944.000+24%
Usd Book Value Change Per Share---0.3900.212-284%-0.274-30%0.101-488%0.084-562%
Usd Book Value Per Share--2.0272.366-14%1.889+7%1.915+6%1.630+24%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps---0.391-0.433+11%-0.562+43%-0.535+37%-0.466+19%
Usd Free Cash Flow---3071399.000-2111773.500-31%-2342963.500-24%-2055583.650-33%-1800595.792-41%
Usd Free Cash Flow Per Share---0.706-0.486-31%-0.539-24%-0.473-33%-0.412-42%
Usd Free Cash Flow To Equity Per Share---0.7060.165-528%0.152-564%209.711-100%174.784-100%
Usd Market Cap5085334.800-23%6261305.7608715220.240-28%10060921.990-38%11786797.600-47%9822331.333-36%
Usd Price Per Share1.170-23%1.4402.005-28%2.315-38%2.712-47%2.260-36%
Usd Profit---1702269.000-1959020.000+15%-2991555.250+76%-2433456.850+43%-2127515.833+25%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.3900.212-284%-0.274-30%0.101-487%0.085-561%
 EOD+3 -5MRQTTM+9 -20YOY+14 -155Y+12 -1910Y+12 -19

4.2. Fundamental Score

Let's check the fundamental score of Hoth Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.747
Price to Book Ratio (EOD)Between0-10.577
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than113.692
Current Ratio (MRQ)Greater than113.892
Debt to Asset Ratio (MRQ)Less than10.074
Debt to Equity Ratio (MRQ)Less than10.080
Return on Equity (MRQ)Greater than0.15-0.193
Return on Assets (MRQ)Greater than0.05-0.179
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Hoth Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.630
Ma 20Greater thanMa 501.291
Ma 50Greater thanMa 1001.314
Ma 100Greater thanMa 2001.317
OpenGreater thanClose1.170
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  33033033033-330



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets9,520
Total Liabilities705
Total Stockholder Equity8,815
 As reported
Total Liabilities 705
Total Stockholder Equity+ 8,815
Total Assets = 9,520

Assets

Total Assets9,520
Total Current Assets9,428
Long-term Assets93
Total Current Assets
Cash And Cash Equivalents 9,292
Other Current Assets 135
Total Current Assets  (as reported)9,428
Total Current Assets  (calculated)9,428
+/-0
Long-term Assets
Property Plant Equipment 55
Long Term Investments 37
Long-term Assets Other 0
Long-term Assets  (as reported)93
Long-term Assets  (calculated)93
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities679
Long-term Liabilities26
Total Stockholder Equity8,815
Total Current Liabilities
Short-term Debt 29
Accounts payable 36
Other Current Liabilities 614
Total Current Liabilities  (as reported)679
Total Current Liabilities  (calculated)679
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt26
Long-term Liabilities  (as reported)26
Long-term Liabilities  (calculated)26
+/-0
Total Stockholder Equity
Common Stock0
Retained Earnings -52,945
Accumulated Other Comprehensive Income 27
Other Stockholders Equity 61,732
Total Stockholder Equity (as reported)8,815
Total Stockholder Equity (calculated)8,815
+/-0
Other
Capital Stock0
Cash and Short Term Investments 9,292
Common Stock Shares Outstanding 4,348
Liabilities and Stockholders Equity 9,520
Net Debt -9,237
Net Invested Capital 8,815
Net Working Capital 8,749
Property Plant and Equipment Gross 55
Short Long Term Debt Total 55



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
> Total Assets 
1,234
1,497
1,497
760
504
504
4,428
4,335
2,836
5,348
7,426
5,950
5,243
20,992
18,029
15,188
10,985
8,945
12,250
9,895
6,759
13,462
11,917
12,086
9,520
9,52012,08611,91713,4626,7599,89512,2508,94510,98515,18818,02920,9925,2435,9507,4265,3482,8364,3354,4285045047601,4971,4971,234
   > Total Current Assets 
0
1,494
1,494
757
502
502
4,226
4,133
2,635
4,897
7,016
5,490
4,783
20,532
17,569
14,778
10,575
8,535
11,863
9,507
6,726
13,429
11,884
12,053
9,428
9,42812,05311,88413,4296,7269,50711,8638,53510,57514,77817,56920,5324,7835,4907,0164,8972,6354,1334,2265025027571,4941,4940
       Cash And Cash Equivalents 
1,230
1,467
1,467
738
283
283
4,093
3,215
1,691
4,349
4,947
4,121
2,630
19,302
15,851
12,445
8,538
6,381
11,318
8,935
6,429
13,044
11,545
11,828
9,292
9,29211,82811,54513,0446,4298,93511,3186,3818,53812,44515,85119,3022,6304,1214,9474,3491,6913,2154,0932832837381,4671,4671,230
       Short-term Investments 
0
0
0
0
0
0
0
804
804
491
2,012
1,290
2,063
1,052
1,576
2,032
1,893
1,915
304
331
209
191
25
25
0
025251912093313041,9151,8932,0321,5761,0522,0631,2902,0124918048040000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
50
50
50
50
0
0
0
0
0
000005050505050000000000000000
       Other Current Assets 
0
0
0
20
219
219
133
114
141
57
57
80
90
178
141
250
94
190
191
191
88
194
315
200
135
13520031519488191191190942501411789080575714111413321921920000
   > Long-term Assets 
0
0
0
3
2
2
202
201
201
451
410
460
460
460
460
410
410
410
387
387
33
33
33
33
93
9333333333387387410410410460460460460410451201201202223000
       Property Plant Equipment 
4
3
3
3
2
2
2
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55
55000000000000001112223334
       Long Term Investments 
0
0
0
0
0
0
0
0
0
250
410
410
410
410
410
410
410
410
387
387
33
33
33
33
37
3733333333387387410410410410410410410410250000000000
       Other Assets 
0
0
0
0
0
200
200
200
200
200
0
50
50
50
50
0
0
0
0
0
0
0
0
0
0
000000000050505050020020020020020000000
> Total Liabilities 
50
129
129
26
349
349
239
25
440
523
590
573
597
1,044
1,454
1,842
1,103
1,061
1,029
1,283
1,638
1,596
1,966
1,579
705
7051,5791,9661,5961,6381,2831,0291,0611,1031,8421,4541,044597573590523440252393493492612912950
   > Total Current Liabilities 
50
129
129
26
349
349
239
25
440
523
355
288
312
759
1,219
1,607
868
826
754
1,008
1,388
1,346
1,716
1,579
679
6791,5791,7161,3461,3881,0087548268681,6071,219759312288355523440252393493492612912950
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
29000000000000000000000000
       Accounts payable 
48
129
129
26
349
142
212
18
404
515
180
23
129
581
805
1,301
361
700
679
931
695
783
521
707
36
367075217836959316797003611,30180558112923180515404182121423492612912948
       Other Current Liabilities 
2
0
0
0
0
207
27
8
36
8
175
265
183
178
414
305
507
126
74
78
693
563
1,195
872
614
6148721,195563693787412650730541417818326517583682720700002
   > Long-term Liabilities 
0
0
0
26
0
142
212
18
404
515
235
285
285
285
235
235
235
235
275
275
250
250
250
0
26
26025025025027527523523523523528528528523551540418212142026000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
235
285
285
285
235
235
235
235
275
275
0
0
250
0
0
00250002752752352352352352852852852350000000000
> Total Stockholder Equity
1,184
1,184
1,368
734
155
155
4,188
4,309
2,396
4,824
6,836
5,377
4,646
19,948
16,575
13,346
9,882
7,884
11,222
8,611
5,122
11,866
9,951
10,507
8,815
8,81510,5079,95111,8665,1228,61111,2227,8849,88213,34616,57519,9484,6465,3776,8364,8242,3964,3094,1881551557341,3681,1841,184
   Common Stock
0
2
2
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
3
0
0
0
0
0
0
0000003222221111111111220
   Retained Earnings Total Equity0000000000-26,951-23,675-19,413-18,657-16,540-14,042-12,216-8,304-6,608-5,340-4,5110000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
-1
-3
-15
-9
0
20
18
14
28
50
22
27
-24
23
27
2723-24272250281418200-9-15-3-10000000000
   Capital Surplus 
0
0
0
0
4,665
10,708
10,795
12,612
14,611
18,865
23,375
24,036
24,073
43,630
43,523
0
0
0
0
0
0
0
0
0
0
000000000043,52343,63024,07324,03623,37518,86514,61112,61210,79510,7084,6650000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
0
0
4,661
0
4,665
10,795
12,612
14,611
18,865
23,375
24,036
24,073
43,630
43,523
43,571
43,589
44,167
50,167
50,182
50,199
59,120
59,130
61,726
61,732
61,73261,72659,13059,12050,19950,18250,16744,16743,58943,57143,52343,63024,07324,03623,37518,86514,61112,61210,7954,66504,661000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-7,692
Operating Income-7,692-7,692
 
Operating Expense (+$)
Research Development3,480
Selling General Administrative4,212
Selling And Marketing Expenses0
Operating Expense7,6927,692
 
Net Interest Income (+$)
Interest Income1
Interest Expense-0
Other Finance Cost-0
Net Interest Income1
 
Pretax Income (+$)
Operating Income-7,692
Net Interest Income1
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,845-7,539
EBIT - interestExpense = 0
-7,845
-7,845
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-7,845
Earnings Before Interest and Taxes (EBITDA)-7,692
 
After tax Income (+$)
Income Before Tax-7,845
Tax Provision-0
Net Income From Continuing Ops-9,622-7,845
Net Income-7,845
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,692
Total Other Income/Expenses Net-153-1
 

Technical Analysis of Hoth Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hoth Therapeutics Inc. The general trend of Hoth Therapeutics Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hoth Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hoth Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.3 < 1.65 < 1.67.

The bearish price targets are: 1.15 > 1.15 > 1.15.

Tweet this
Hoth Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hoth Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hoth Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hoth Therapeutics Inc. The current macd is -0.05049632.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hoth Therapeutics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hoth Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hoth Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hoth Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartHoth Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hoth Therapeutics Inc. The current adx is 23.11.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hoth Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Hoth Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hoth Therapeutics Inc. The current sar is 1.41338483.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hoth Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hoth Therapeutics Inc. The current rsi is 40.63. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Hoth Therapeutics Inc Daily Relative Strength Index (RSI) ChartHoth Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hoth Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hoth Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Hoth Therapeutics Inc Daily Stochastic Oscillator ChartHoth Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hoth Therapeutics Inc. The current cci is -87.47884017.

Hoth Therapeutics Inc Daily Commodity Channel Index (CCI) ChartHoth Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hoth Therapeutics Inc. The current cmo is -24.97354481.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hoth Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartHoth Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hoth Therapeutics Inc. The current willr is -93.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Hoth Therapeutics Inc Daily Williams %R ChartHoth Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hoth Therapeutics Inc.

Hoth Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hoth Therapeutics Inc. The current atr is 0.1002002.

Hoth Therapeutics Inc Daily Average True Range (ATR) ChartHoth Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hoth Therapeutics Inc. The current obv is 149,814,286.

Hoth Therapeutics Inc Daily On-Balance Volume (OBV) ChartHoth Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hoth Therapeutics Inc. The current mfi is 19.23.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Hoth Therapeutics Inc Daily Money Flow Index (MFI) ChartHoth Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hoth Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Hoth Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hoth Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.630
Ma 20Greater thanMa 501.291
Ma 50Greater thanMa 1001.314
Ma 100Greater thanMa 2001.317
OpenGreater thanClose1.170
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hoth Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Hoth Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hoth Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hoth Therapeutics Inc

I send you an email if I find something interesting about Hoth Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Hoth Therapeutics Inc.

Receive notifications about Hoth Therapeutics Inc in your mailbox!